Literature DB >> 30602133

Bioactive butylphthalide derivatives from Ligusticum chuanxiong.

Xu Zhang1, Zi-Ming Feng1, Ya-Nan Yang1, Jian-Shuang Jiang1, Pei-Cheng Zhang2.   

Abstract

Seven new butylphthalide derivatives, ligusticumolide A-G (1-7), together with two known butylphthalide derivatives (8-9) were isolated from an ethanol extract of Ligusticum chuanxiong Hort. The structures of these derivatives were elucidated from analysis of 1D/2D NMR, UV, IR and HRESIMS data. The absolute configurations of these derivatives were determined by electronic circular dichroism (ECD) calculations and Mosher's method. Ligusticumolide A (1) and ligusticumolide B (2) are enantiomers that were obtained by chiral separation. Ligusticumolide C (3) and ligusticumolide D (4) are diastereomers. All of the compounds were evaluated for their hepatoprotective activity against N-acetyl-p-aminophenol-induced HepG2 cell injury. Compounds 4, 5, and 7-9 showed more significant hepatoprotective activity than that of the positive control drug (bicyclol) at a concentration of 10 μM (p < 0.01).
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Butylphthalide derivatives; Hepatoprotective activity; Ligusticum chuanxiong; Structure elucidation

Mesh:

Substances:

Year:  2018        PMID: 30602133     DOI: 10.1016/j.bioorg.2018.12.032

Source DB:  PubMed          Journal:  Bioorg Chem        ISSN: 0045-2068            Impact factor:   5.275


  6 in total

1.  Studying Mass Balance and the Stability of (Z)-Ligustilide from Angelica sinensis Helps to Bridge a Botanical Instability-Bioactivity Chasm.

Authors:  Kemal Duric; Yang Liu; Shao-Nong Chen; David C Lankin; Dejan Nikolic; James B McAlpine; J Brent Friesen; Guido F Pauli
Journal:  J Nat Prod       Date:  2019-09-03       Impact factor: 4.050

2.  Characterization of thrombin/factor Xa inhibitors in Rhizoma Chuanxiong through UPLC-MS-based multivariate statistical analysis.

Authors:  Yi-Yao Yang; Zhao-Yu Wu; Fang-Bo Xia; Hao Zhang; Xu Wang; Jian-Li Gao; Feng-Qing Yang; Jian-Bo Wan
Journal:  Chin Med       Date:  2020-08-31       Impact factor: 5.455

3.  Key Phytochemicals and Biological Functions of Chuanxiong Rhizoma Against Ischemic Stroke: A Network Pharmacology and Experimental Assessment.

Authors:  Peng Zeng; Yao Yi; Hong-Fei Su; Chao-Yuan Ye; Yi-Wen Sun; Xin-Wen Zhou; Youming Lu; Anbing Shi; Qing Tian
Journal:  Front Pharmacol       Date:  2021-12-21       Impact factor: 5.810

4.  Two Novel Phenylpropanoid Trimers From Ligusticum chuanxiong Hort With Inhibitory Activities on Alpha-Hemolysin Secreted by Staphylococcus aureus.

Authors:  Shi-Jie Wan; Han-Gui Ren; Jia-Ming Jiang; Gang Xu; Yu Xu; Si-Min Chen; Gan Chen; Dan Zheng; Man Yuan; Hong Zhang; Hong-Xi Xu
Journal:  Front Chem       Date:  2022-03-30       Impact factor: 5.221

5.  Molecular mechanism of Chuanxiong Rhizoma in treating coronary artery diseases.

Authors:  Bang-Qiao Yin; Yu-Hong Guo; Yuan Liu; Yang-Yang Zhao; Shan-Mei Huang; Xia-Wei Wei; Heng-Sheng Wang; Ruo-Ya Liu; Ying Liu; Yao-Ping Tang
Journal:  Chin Herb Med       Date:  2021-03-17

6.  Senkyunolide H Affects Cerebral Ischemic Injury through Regulation on Autophagy of Neuronal Cells via P13K/AKT/mTOR Signaling Pathway.

Authors:  Bei Zhao; Ke-Cheng Tang; Ying Zhao; Wang Zhao
Journal:  Dis Markers       Date:  2022-10-03       Impact factor: 3.464

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.